Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
J Am Soc Nephrol. 2020 Aug;31(8):1836-1846. doi: 10.1681/ASN.2019101106. Epub 2020 Jun 23.
Risk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through proinflammatory and vitamin D-suppressing pathways. Whether FGF23 is associated with risk of infection has not been evaluated in a CKD population.
In 3655 participants of the Chronic Renal Insufficiency Cohort study, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hospitalization with major infection, defined by hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia. Multivariable Cox models were used to estimate hazard ratios (HRs) and adjust for confounding.
During a median follow-up of 6.5 years, 1051 individuals (29%) were hospitalized with major infection. Multivariable Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1.51; 95% CI, 1.23 to 1.85 with the highest quartile [≥235.9 RU/ml] versus lowest quartile [<95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23). The association was consistent across infection subtypes and demographic and clinical subgroups, and remained significant after additional adjustment for biomarkers of inflammation (IL-6, TNF-, high-sensitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin D, phosphorus, calcium, and parathyroid hormone). The association was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cases), and bacteremia/septicemia (280 cases).
Among individuals with CKD, higher FGF23 levels were independently and monotonically associated with an increased risk of hospitalization with infection.
患有 CKD 的个体感染传染病的风险增加。成纤维细胞生长因子 23(FGF23)在 CKD 中常升高,并且可能通过促炎和抑制维生素 D 的途径直接或间接损害免疫功能。在 CKD 人群中,尚未评估 FGF23 是否与感染风险相关。
在慢性肾功能不全队列研究的 3655 名参与者中,我们评估了基线时 C 端 FGF23 血浆水平与首次因主要感染住院的时间之间的关联,主要感染定义为因尿路感染、肺炎、蜂窝织炎/骨髓炎或菌血症/败血症而住院的出院诊断。多变量 Cox 模型用于估计危险比(HR)并调整混杂因素。
在中位随访 6.5 年期间,1051 名患者(29%)因主要感染住院。多变量 Cox 分析表明,随着 FGF23 水平的升高,感染风险呈梯度增加(HR,1.51;95%CI,最高四分位[≥235.9 RU/ml]与最低四分位[<95.3 RU/ml];HR,1.26;95%CI,1.18 至 1.35,每 SD 对数 FGF23 增加)。该关联在感染亚型和人口统计学及临床亚组中一致,并且在进一步调整炎症生物标志物(IL-6、TNF-、高敏 C 反应蛋白、纤维蛋白原和白蛋白)和骨矿物质代谢(25-羟维生素 D、磷、钙和甲状旁腺激素)后仍然显著。该关联在尿路感染(482 例)、蜂窝织炎/骨髓炎(422 例)、肺炎(399 例)和菌血症/败血症(280 例)的感染亚型中一致。
在患有 CKD 的个体中,较高的 FGF23 水平与感染住院风险的增加独立且单调相关。